ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 252

$903K Total Retail Price of All Prescriptions

Rank: 20 out of 252

636 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 20,718 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 1,237 947 1 2
PRAVASTATIN SODIUM 1,165 862 2 12
AMLODIPINE BESYLATE 838 652 3 4
LISINOPRIL 814 665 4 3
FUROSEMIDE 773 604 5 7
HYDROCODONE-ACETAMINOPHEN 730 345 S3 6 5
LEVOTHYROXINE SODIUM 621 470 7 1
METFORMIN HCL 600 453 8 9
OMEPRAZOLE 577 395 9 6
WARFARIN SODIUM 496 400 10 14
MELOXICAM 377 320 11 20
METOPROLOL TARTRATE 372 303 12 10
POTASSIUM CHLORIDE 370 290 13 8
TRAMADOL HCL 361 272 14 17
FLUTICASONE PROPIONATE 315 233 15 36
METOPROLOL SUCCINATE 312 280 16 19
ZOLPIDEM TARTRATE 307 232 17 21
GABAPENTIN 299 192 18 11
ENALAPRIL MALEATE 288 224 19 72
GLYBURIDE 283 186 R 20 78
CARVEDILOL 274 208 21 22
DICLOFENAC SODIUM 263 160 22 128
GLIMEPIRIDE 257 209 23 40
DONEPEZIL HCL 252 246 24 28
CLONIDINE HCL 252 200 24 35
GLYBURIDE-METFORMIN HCL 245 152 R 26 82
CITALOPRAM HBR 243 181 27 15
LOVASTATIN 236 201 28 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 236 187 28 25
HYDROCHLOROTHIAZIDE 231 181 30 13
RANITIDINE HCL 229 180 31 48
ALENDRONATE SODIUM 225 203 32 32
NAMENDA 220 220 33 41
TAMSULOSIN HCL 219 167 34 26
LACTULOSE 209 164 35 157
AMITRIPTYLINE HCL 202 114 R 36 46
DOXAZOSIN MESYLATE 198 125 37 73
DIGOXIN 197 171 38 44
TRIAMTERENE-HCTZ 195 133 39 33
AMLODIPINE BESYLATE-BENAZEPRIL 193 166 40 60
FINASTERIDE 182 164 41 115
ATENOLOL 178 123 42 18
SERTRALINE HCL 175 100 43 27
VENTOLIN HFA 170 96 44 102
ISOSORBIDE MONONITRATE ER 169 91 45 50
ALLOPURINOL 158 133 46 30
CYCLOBENZAPRINE HCL 158 109 R 46 51
VERAPAMIL ER 151 114 48 83
OXYBUTYNIN CHLORIDE 148 133 49 123
METOCLOPRAMIDE HCL 147 109 50 110
PAROXETINE HCL 143 88 51 75
PREDNISONE 138 94 52 42
FENOFIBRATE 137 99 53 64
SPIRONOLACTONE 137 111 53 53
MIRTAZAPINE 136 93 55 58
PROAIR HFA 131 80 56 54
HUMULIN N 130 95 57 247
TRAZODONE HCL 130 107 57 31
QUETIAPINE FUMARATE 127 114 59 77
NEXIUM 127 70 59 23
KLOR-CON M20 126 94 61 69
RISPERIDONE 123 80 62 81
METHYLPREDNISOLONE 123 101 62 118
AMOXICILLIN 121 67 64 122
CLOPIDOGREL 120 95 65 29
POLYETHYLENE GLYCOL 3350 119 116 66 67
SUCRALFATE 119 84 66 125
CEFUROXIME 116 81 68 114
PHENYTOIN SODIUM EXTENDED 116 44 68 103
MEGESTROL ACETATE 113 108 R 70 138
NOVOLIN N 112 88 71 284
PLAVIX 112 90 71 43
LABETALOL HCL 112 60 71 150
AZITHROMYCIN 108 72 74 37
HYDRALAZINE HCL 108 59 74 95
TRIAMCINOLONE ACETONIDE 97 72 76 147
CARBIDOPA-LEVODOPA 94 90 77 107
BENAZEPRIL HCL 93 77 78 80
EVISTA 90 90 79 91
ROPINIROLE HCL 87 79 80 84
PANTOPRAZOLE SODIUM 85 67 81 62
CIPROFLOXACIN HCL 83 70 82 61
MECLIZINE HCL 81 66 83 136
ESTRADIOL 80 71 R 84 76
BUPROPION XL 80 72 84 188
NAPROXEN 80 57 84 96
DILTIAZEM ER 80 60 84 86
ESCITALOPRAM OXALATE 76 67 88 56
LEVOFLOXACIN 76 67 88 79
ATORVASTATIN CALCIUM 76 58 88 16
PREMARIN 74 67 R 91 116
IPRATROPIUM-ALBUTEROL 74 65 91 155
FLUOXETINE HCL 71 32 93 57
PROPAFENONE HCL 71 71 93 221
INSULIN SYRINGE 71 61 93 93
PROPRANOLOL HCL 68 32 96 111
RAMIPRIL 68 49 96 71
LOSARTAN POTASSIUM 67 25 98 24
SEROQUEL 65 60 99 149
PROMETHAZINE HCL 65 53 R 99 85
CARISOPRODOL 65 0 R 99 70
NOVOLIN R 64 60 102 190
GLIPIZIDE 63 63 103 52
HUMULIN R 62 53 104 202
HYDROXYZINE HCL 60 39 R 105 184
NITROSTAT 60 27 105 189
SOTALOL 60 49 105 205
ENALAPRIL-HYDROCHLOROTHIAZIDE 58 53 108 279
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 109 49
DIOVAN 57 46 109 38
GLIPIZIDE ER 55 53 111 90
FAMOTIDINE 55 41 111 59
MINOXIDIL 55 38 111 345
GEMFIBROZIL 55 39 111 98
DIOVAN HCT 55 37 111 65
CYMBALTA 54 50 116 45
DICYCLOMINE HCL 54 43 116 216
TOPIRAMATE 53 0 118 151
LEVETIRACETAM 53 30 118 131
TRICOR 50 48 120 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.